In the regulatory arena, one of the most significant events relating to excipients, in my opinion, was the presentation by Brian Hasselbalch of the FDA’s Division of Manufacturing and Product Quality, Office of Compliance at the Global Outsourcing Conference held at Xavier University in June this year.
read more